![Mayo Clinic home page [logo]](/images-global/mayologo.gif)
Share this site with others using one of these sharing tools.
To link to this article, paste this block of HTML code onto your webpage.
Guidelines for sites linking to mayoclinic.orgMayo Clinic researchers have contributed to the understanding and treatment of sclerosing mesenteritis (SM). Mayo studies suggest that symptomatic patients can benefit from a combination of two drugs, tamoxifen and prednisone. Long-term follow-up is needed to confirm this finding.
Mayo Clinic researchers are conducting the largest study of sclerosing mesenteritis patients to date. They are reviewing the records of all SM patients seen at Mayo to learn about the disease's clinical features and the effectiveness of treatments.
See a list of publications by Mayo Clinic doctors on sclerosing mesenteritis on PubMed, a service of the National Library of Medicine.
Research descriptions of individual investigators:
.
